Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-10

Clinical Trial Update: Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min). [Phase 3]

View source ↗

Summary

A Phase 3 trial update examining the differential effect of a high adenosine dose on fractional flow reserve. It focuses on coronary artery disease patients who…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenosine (Adenosine)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED